Stocks · Health care · Biological Products, (No Diagnostic Substances)

LeonaBio, Inc.

LONA Clue Score29
United States Fiscal year ends December CIK 0001620463 Results filed 14 Aug 2026

What the insiders did Net selling

By person

7 insiders · 12 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mark James Litton
PRESIDENT and CEO
—
$45.48K (2)
−$45.48K
57,926
$182.44M
—
Martin Javier San
Chief Medical Officer
—
$20.55K (2)
−$20.55K
15,887
$50.04M
—
Kevin Church
Chief Scientific Officer
—
$13.32K (2)
−$13.32K
25,178
$79.30M
—
Mark Worthington
GENERAL COUNSEL and CCO
—
$13.16K (2)
−$13.16K
18,376
$57.87M
—
Robert Renninger
Chief Financial Officer
—
$6.91K (2)
−$6.91K
15,851
$49.92M
—
David J. Portman
10% owner
— (1)
—
$0.00
3,149,470
$9.92B
—
Perceptive Advisors LLC entity
Director
—
—
—
659,512
$2.08B
—

No percentages here. This company's share count has moved by a factor of 10.0 over the window, from 3,943,887 to 39,439,326 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.